These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1247 related items for PubMed ID: 24020938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M, Belhassen B, Hochenberg M, Viskin S.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):320-8. PubMed ID: 17239713
    [Abstract] [Full Text] [Related]

  • 6. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
    Chiladakis J, Kalogeropoulos A, Zagkli F, Koutsogiannis N, Chouchoulis K, Alexopoulos D.
    Cardiology; 2012 Jan 23; 122(1):3-11. PubMed ID: 22626988
    [Abstract] [Full Text] [Related]

  • 7. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC.
    Psychosomatics; 2013 Jan 23; 54(1):1-13. PubMed ID: 23295003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C, Fitzgibbons TP, Alsheikh-Ali AA, Bouchard JL, Kalsmith B, Garlitski AC, Tighe DA, Estes NA, Aurigemma GP, Link MS.
    Heart Rhythm; 2011 Apr 23; 8(4):555-61. PubMed ID: 21146632
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.
    Tisdale JE.
    Can Pharm J (Ott); 2016 May 23; 149(3):139-52. PubMed ID: 27212965
    [Abstract] [Full Text] [Related]

  • 11. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
    Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchie MD, Roden DM.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):836-42. PubMed ID: 18294569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Personalized, intuitive & visual QT-prolongation monitoring using patient-specific QTc threshold with pseudo-coloring and explainable AI.
    Alahmadi A, Davies A, Vigo M, Jay C.
    J Electrocardiol; 2023 Feb 26; 81():218-223. PubMed ID: 37837739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
    Lin YL, Kung MF.
    Pharmacoepidemiol Drug Saf; 2009 Mar 26; 18(3):235-9. PubMed ID: 19145580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Torsades de pointes and long QT syndromes.
    Janeira LF.
    Am Fam Physician; 1995 Oct 26; 52(5):1447-53. PubMed ID: 7572567
    [Abstract] [Full Text] [Related]

  • 19. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS, Nam GB, Kim YG, Hwang KW, Kim YR, Choi H, Kim SH, Rhee KS, Kim NJ, Kim JS, Kim J, Choi KJ, Kim YH.
    Heart Rhythm; 2015 Mar 26; 12(3):498-505. PubMed ID: 25460857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.